Details for New Drug Application (NDA): 072168
✉ Email this page to a colleague
The generic ingredient in CYTARABINE is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 072168
Tradename: | CYTARABINE |
Applicant: | Hospira |
Ingredient: | cytarabine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 072168
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 072168
Suppliers and Packaging for NDA: 072168
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYTARABINE | cytarabine | INJECTABLE;INJECTION | 072168 | ANDA | Hospira, Inc. | 61703-303 | 61703-303-46 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (61703-303-46) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | Aug 31, 1990 | TE: | AP | RLD: | No |
Complete Access Available with Subscription